American Alpha Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
American Alpha Advisors's REGN Position: Q2 2026 in Review
American Alpha Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q2 2026, buying an estimated $5.45K and bringing the position to 476 shares worth $297K. The position accounts for 0.16% of the portfolio, ranked #82.
American Alpha Advisors first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $362K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- American Alpha Advisors held 476 shares of Regeneron Pharmaceuticals worth $297K as of Q2 2026.
- American Alpha Advisors bought 8 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.45K.
- Regeneron Pharmaceuticals made up 0.16% of American Alpha Advisors's portfolio in Q2 2026, its #82 holding.
- American Alpha Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- American Alpha Advisors's Regeneron Pharmaceuticals position peaked at $362K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on American Alpha Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.